{
  "id": "mhgap#risk_safety_0407aeeb",
  "content": "If the first monotherapy is not successful for generalized onset seizures, an\nalternative first-line monotherapy should be tried.\nValproic acid (sodium valproate) is not recommended in women and\ngirls of childbearing potential owing to the high risk of birth defects and\nneurodevelopmental disorders in children exposed to valproic acid (sodium\nvalproate) in the womb.\nIf lamotrigine, levetiracetam and valproic acid (sodium valproate) are not\navailable for generalized onset seizures, monotherapy with either phenytoin\nor phenobarbital can be considered.\nStrength of recommendation: Strong\nCertainty of evidence: High\n3.2 Focal onset seizures:\nMonotherapy with lamotrigine or levetiracetam should be offered as first-line\ntreatment for focal onset seizures in children and adults with epilepsy.\nIf neither lamotrigine nor levetiracetam are available, then carbamazepine\nshould be used as an alternate first-line treatment for focal onset seizures in\nchildren and adults with epilepsy.\nIf the first monotherapy is not successful for focal onset seizures, an\nalternative first-line monotherapy should be tried.\nLacosamide should be offered as a second-line monotherapy for focal onset\nseizures if none of the first-line medicines are effective.\nIf antiseizure medicine monotherapy is unsuccessful in people with\ngeneralized onset seizures or focal onset seizures, prompt referral should be",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Risk Safety If the first monotherapy is not successful for generalized onset seizures, an\nalternative first-line monotherapy should be tried.\nValproic acid (sodium valproate) is not recommended in women and\ngirls of childbearing potential owing to the high risk of birth defects and\nneurodevelopmental disorders in children exposed to valproic acid (sodium\nvalproate) in the womb.\nIf lamotrigine, levetiracetam and valproic acid (sodium valproate) are not\navailable for generalized onset seizures, monotherapy with either phenytoin\nor phenobarbital can be considered.\nStrength of recommendation: Strong\nCertainty of evidence: High\n3.2 Focal onset seizures:\nMonotherapy with lamotrigine or levetiracetam should be offered as first-line\ntreatment for focal onset seizures in children and adults with epilepsy.\nIf neither lamotrigine nor levetiracetam are available, then carbamazepine\nshould be used as an alternate first-line treatment for focal onset seizures in\nchildren and adults with epilepsy.\nIf the first monotherapy is not successful for focal onset seizures, an\nalternative first-line monotherapy should be tried.\nLacosamide should be offered as a second-line monotherapy for focal onset\nseizures if none of the first-line medicines are effective.\nIf antiseizure medicine monotherapy is unsuccessful in people with\ngeneralized onset seizures or focal onset seizures, prompt referral should be If the first monotherapy is not successful for generalized onset seizures, an\nalternative first-line monotherapy should be tried. valproic acid (sodium valproate) is not recommended in women and\ngirls of childbearing pot..."
}